Tag | Content |
---|
EnhancerAtlas ID | HS127-19863 |
Organism | Homo sapiens |
Tissue/cell | Macrophage |
Coordinate | chr21:34710900-34713300 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
FOXC1 | MA0032.2 | chr21:34712452-34712463 | TATGTAAACAT | + | 6.32 | MEF2C | MA0497.1 | chr21:34713167-34713182 | AAACCAAAAATAGAA | + | 6.95 | NFYA | MA0060.3 | chr21:34712414-34712425 | TCTGATTGGCC | - | 6.02 | NFYB | MA0502.1 | chr21:34712415-34712430 | CTGATTGGCCAGTTC | - | 6.6 | RARA | MA0729.1 | chr21:34712763-34712781 | AAATGACCCTCTCACCTC | - | 6.17 | SPIC | MA0687.1 | chr21:34712302-34712316 | TTCTTCCCCTTTCT | - | 6.03 | STAT3 | MA0144.2 | chr21:34711868-34711879 | CTTCCCAGAAG | - | 6.14 |
|
| Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
SE_10924 | chr21:34709185-34714632 | CD20 | SE_43680 | chr21:34711024-34712733 | MM1S |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 2 | Chromosome | Start | End |
chr21 | 34711429 | 34711719 | chr21 | 34711282 | 34712769 |
|
| Number: 1 | ID | Chromosome | Start | End |
GH21I033339 | chr21 | 34712107 | 34712506 |
|
Enhancer Sequence | TAGACTGCCT CAGTGAACAG GAGAGGCAAA GATGGCATGA AGTTATATTA TGAAACGGAT 60 TTCATGAAGT AAATATTACA TTAGTTACAT ATTCATATTT CATATTCTGT TCTGAGCTAA 120 TTATTGCATA TGATAATAGT TTTTTTGTTG TTGGTTTTTT TTTTTTGAGA CGGAGTCTTG 180 CTCTGTTGCC CAGGCTGGAG TGCAATGGCG CAATCTCGGC TCACCGCAAC CTCCGCCTCC 240 CGGGTTCAAG CAATTCTCCT GTCTCAGCCT CCCGAGTGCC TGGGATTACA GGCATGCACC 300 CCCACGCCCG GCTAATTTTG TATTTTTAGT AGAGACAGGA TTTCTCCATG TTGATCGGGC 360 TGATCTCGAA CTCCTGATCT CAAGTGATCC ACCCCCCTCG GCCTCCCAAA GTGCTGGGAT 420 TACAGGTGTG AGCCACCGAG CCCGGCCAAT AATGATTTTT TTAAGAAAAT ATAAAAGTAG 480 CTTCTGCTGC AATATCTTGA TTAGATGTAA AACAGTTTTA ATGGAGCATG CTTCAGCATC 540 TCCTGAAGTA GGAAAGACAG ATGTAAACAG TGAGGTTGGG TTGAAATTAT ATTAAGTTTT 600 AAATTTTTGA TAAGGTTTTC TGTTTATAAT GAGAGTTTCT GGATTTTTAG AAATAGATTC 660 TGATGTGGAA CCTTTTCAAG AATGTTTAAG GTATTTTTAA TGCCAGCTCT AATCTCAGGC 720 CTCAGATATG TAAAAGTGGA AGTGAAAACT GGCCAAGAAT GAAGTATTTC ATATGCTAGT 780 GTATATTTTT GGTAATTTCT TAAAAATGTT TCCATTTTGA AAAACAAGGT AGACTTGTAT 840 TTGGTTCAGC AACAAAATTA TTTTGGTATT ATCTCTGGTT TCTAATATCT AAATCGTCTT 900 TAAAATGGCA TCTGTGATAT TATTAAAAAT AAATAAATCA GCTAATGAAT TAGGCTTGAC 960 AAAAATGCCT TCCCAGAAGA TAGTTTCTCT GCTACTTATG GTCAATGGGC TTAACATAGG 1020 TAAAAGTTCT CAAATCTGCT AAATTGGCCG GGCATGGTGG CTCACGCCTG TAATCCCAGC 1080 ACTTTGGGAG GCTGAGGTGG GCAGATCACC TGAGGTGAGG AGTTTAAGAT CAGTCTAGCC 1140 AACATGGCAA AACCCCATCT CTACTAAAAA AAAAAATACA AAAATTAGCC AGACGTGGTG 1200 GCACACGCCT GTAATCACAG CTAGTTGAGA GGCTGAGGCA GGAGAATTGC TTGAACCTAG 1260 GAAGTGGAGG TTGCAGTGGG CCGAGATTGC ACCACTGCAC TCCAGCCTGG GCAACAGAGT 1320 AAGACTCTGT CTCAAAAAAA AAAAAAAAAA AAAAAAGAAA TCTGCTAAGT TCGTTTCTAT 1380 CCCTCACTTT CCCTGCAAGC TCTTCTTCCC CTTTCTGGGC AACATGTCCT TTTCTGCTTT 1440 AGGCACTCCA TGCCCACTTT ATTTTTCATG TTTGCCCCTT TTTTGAAAGG AAGAATCTAA 1500 TATCACTTCA GCTTTCTGAT TGGCCAGTTC CACTTCCAAA AATTTATTTG TTTATGTAAA 1560 CATTTTCAGT TTTGTGGTTT CTGATGATGT AATAGAAGAA ATTACGGAGA CAGGCAAGCA 1620 GAAGGGATGG TTTGCTTTTG GAGAGGGCAG AGGAAACCTT GAAACCATAC TGATTCTGAG 1680 GTCTTTCTTA GGGAAGGTAA GTCTATTCAT AGGAGGAGGT CAGAAGGGAA TCATCAAATC 1740 CAATTCCCCA GTTTCTATTT AATTTTATTT TATTAGAGAC AGGGTCTTGC TCGGTTGCTG 1800 AGGCTGGAGT GCAGTGATAT GATCATAGCC TACTGCAGCC TGCAGCCTTG AACCCCTATG 1860 CTCAAATGAC CCTCTCACCT CAGCCTACCC AGTAGCTAGG ACTGTGGGCA TGTGCCACCA 1920 TGCCCTGCTT TGCCTTTTTT TTTTTTTATT TCTCATAGAG ACAGGGTTTG CTATGTTGAC 1980 CAGGCTCCAA ACTTTCAATA AGGAAGATAA GATCCAGAAA CACAAAATAG TTTACCAAAA 2040 GTCACACAGC TATTTTTAAC AGAGCCAACA TACTAAATCC ACTTTTACCT TATGGGTCAT 2100 TTATTTCTCT GCTTCCTGAA GCAACCACCC ACAAAATTAT ATAAAGAACT GTATTTTAAA 2160 ATTCAGTTTC ATAAGTAATA ACTTGGCTTA TATGCATTGA AAAAGAGTGG AAGGGTGTAT 2220 GCTAAAATGT TAATAGGACA TTAGCTCAAG TAGAAGAAAT AACTCTTAAA CCAAAAATAG 2280 AAATAACTCT TAAACAAGAG TTATTAAGAG TTAAGAAATA ACTCTTATAC CAGTAAATAG 2340 AAAGTATTTG ACACTTACAT TTATACATTT GCTCACTCAT TCATTTGTTT TTTTTACTTT 2400
|